TGA Approval

IMBRUVICA ibrutinib 280 mg film-coated tablet blister (319357)

ARTG ID

319357

ARTG Name

IMBRUVICA ibrutinib 280 mg film-coated tablet blister

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

August 4, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01679-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01676-1

Ingredient Name

ibrutinib

Empowering clinical research with data-driven insights and AI-powered tools.

IMBRUVICA ibrutinib 280 mg film-coated tablet blister (319357) - TGA 批准文号 | MedPath